insights_auto
Outlook: 50.0% bullish·5.0% bearish
Go to analysischevron_right
MRCK34:BVMF
Merck BDR
R$91.99
0.00%
(0.00) 1D
Oct 9, 5:11:07 PM GMT-3 · BRL
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MRCK34...
Open
R$89.63
High
R$91.99
Low
R$88.70
Mkt. cap
359.22B
Avg. vol.
7.33K
Volume
6.49K
52-wk high
R$100.98
52-wk low
R$54.17
Shares outstanding
2.47B
No. of employees
74K
Open
R$89.63
High
R$91.99
Low
R$88.70
Mkt. cap
359.22B
Avg. vol.
7.33K
Volume
6.49K
52-wk high
R$100.98
52-wk low
R$54.17
Shares outstanding
2.47B
No. of employees
74K
News stories
From web sources and news partners
MarketBeat
·
1 hour ago
Merck & Co., Inc. $MRK Shares Sold by Castle Rock Wealth Management LLC
Yahoo Finance
·
6 hours ago
Merck (MRK) Stock Trades Below Fair Value Despite Its 117% Run
Trefis
·
14 hours ago
Does The Move In Merck Stock Change Anything?
24/7 Wall St.
·
15 hours ago
Novavax Soars 16%, Moderna Surges 11%, Merck Climbs 3% as Biotech Rallies
Profile
Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. The company is ranked fifth on the list of largest biomedical companies by revenue.
The company's revenues are primarily from cancer treatments, vaccines, and animal health products. In 2024, 46% of the company's revenue, or $29.5 billion, came from sales of Keytruda, a PD-1 inhibitor used to treat various types of cancers, and 13% of the company's revenue, or $8.6 billion, came from sales of Gardasil, an HPV vaccine. In addition, 9% of the company's revenue, or $5.8 billion, came from the sales of animal health products.
The company is ranked 65th on the Fortune 500 and 76th on the Forbes Global 2000.
In 1891, Merck & Co. was established as the American affiliate of the Merck Group, founded by the Merck family, and the companies are still in trademark disputes in several countries over the right to use the name "Merck". Wikipedia
About Merck BDR
CEORobert M Davis
Employees74K
FoundedJan 1, 1891
Headquarters-
SectorPharmaceutical industry
Websitemerck.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
Revenue | 17.28B | 16.40B | 16.29B | 16.61B |
Cost of goods sold | 3.74B | 4.30B | 3.88B | 4.13B |
Cost of revenue | 3.74B | 4.30B | 3.88B | 4.13B |
Research and development expenses | 4.00B | 4.00B | 3.56B | 9.74B |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 2.48B | 2.73B | 2.57B | 2.78B |
Operating expense | 6.48B | 6.73B | 6.12B | 12.52B |
Total operating expenses | 10.23B | 11.02B | 10.00B | 16.65B |
Operating income | 7.05B | 5.38B | 6.29B | -40.00M |
Other non operating income | - | 41.00M | 42.00M | 59.00M |
EBT including unusual items | 6.74B | 3.42B | -3.53B | -683.00M |
EBT excluding unusual items | 6.76B | 4.98B | 5.85B | -508.00M |
Income tax expense | 958.00M | 458.00M | 709.00M | 654.00M |
Effective tax rate | 14.20% | 13.39% | -20.06% | -95.75% |
Other operating expenses | - | - | - | - |
Net income | 5.78B | 2.96B | -4.24B | -1.34B |
Net profit margin | 33.49% | 18.07% | -26.03% | -8.04% |
Earnings per share | 2.58 | 2.04 | -1.28 | -0.13 |
Interest and investment income | 96.00M | 69.00M | 35.00M | 35.00M |
Interest expense | -327.00M | -411.00M | -479.00M | -525.00M |
Net interest expenses | -231.00M | -342.00M | -444.00M | -490.00M |
Depreciation and amortization charges | - | - | - | - |
EBITDA | 8.15B | 6.79B | 7.69B | 1.43B |
Gain or loss from assets sale | - | - | - | - |